查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1829583

分子育种市场（按作物类型、产品类型、最终用户和应用）—2025-2032 年全球预测

Molecular Breeding Market by Crop Type, Product Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年分子育种市场将成长至 111.7 亿美元，复合年增长率为 12.56%。

主要市场统计数据
基准年2024年 43.3亿美元
预计2025年 48.7亿美元
预测年份：2032年 111.7亿美元
复合年增长率（%） 12.56%

综合运用技术与管理能力，加速分子育种，重组作物改良管道

分子育种是基因组学、高通量表型分析和计算分析的交叉领域，为加速作物改良奠定了基础。过去十年，定序通量的提升、基因型鉴定成本的降低以及表型分析的改进，彻底改变了育种流程的设计和执行方式，使研发团队能够缩短育种週期、提高选择精度，并在不同的环境条件下检验复杂性状。

本报告综合了分子育种生态系统的发展，揭示了技术整合如何改变相关人员的行为、资本配置和伙伴关係模式。报告检验了渐进式流程改善和模式转移，这些改进和转变使得更具预测性的育种策略成为可能。重要的是，本分析将最新的技术进步置于实际营运中，从供应链依赖到监管约束，为读者提供了一个将方法层面的创新与商业性成果联繫起来的整体观点。

为企业领导者、投资者和研究负责人提供的背景介绍，组装了变革的关键驱动因素、典型的应用路径以及值得策略关注的新兴价值池，为后续章节奠定了基础。透过建立这一基准，后续章节阐明了哪些领域最有可能出现颠覆，以及哪些领域需要深思熟虑的干预才能带来显着回报。

技术、监管和商业性动态的整合如何重塑整个分子育种生态系统的营运控制和竞争优势

在技​​术、监管和商业性动态整合的推动下，分子育种领域正在经历一系列变革。基因型鉴定平台正从专业化的核心设施转向可用于分散育种站的模组化设备，将资料产生的控制权更紧密地转移到育种者手中。基于影像和感测器辅助的表型分析技术的同步发展正在提高时间分辨率和性状保真度，从而能够发现先前在田间试验中被掩盖的细微基因型与环境相互作用。

同时，软体和分析技术正在从说明报告发展到整合多组体学层面的预测建模和决策支援系统。这种转变鼓励多学科团队将资料科学家纳入育种计划，并推动了对可互通资料标准和云端原生架构的需求。法律规范也在不断调整。各国司法管辖区对基因编辑品种的途径进行了明确，这正在刺激投资，并促进更快的测试和商业化进程。

商业性，伙伴关係正变得更加灵活和以结果为导向，许可、数据共用和基于绩效的合约正成为协调技术提供者、种苗公司和研究机构之间奖励的首选机制。这些转变正在共同改变该产业的时机、风险分配和竞争优势的定位。

评估2025年美国关税如何改变分子育种相关人员的采购、供应链弹性和营运时间表

美国关税于2025年生效，对分子育种相关人员的采购、供应链弹性和商业化时间表产生了连锁影响。实验室设备组件和某些特殊耗材的关税增加了设备和试剂的到岸成本，促使采购团队重新评估筹资策略和库存政策。因此，一些组织转向多方采购和近岸外包以降低风险，而另一些组织则延长了设备生命週期并加快了对替代供应商的检验。

这些贸易政策变化也提高了关键设备和高价值耗材国内製造能力的重要性。拥有国内生产或长期供应商伙伴关係的公司获得了采购优势，而依赖单一来源进口的小型研究机构则遭遇了计划延期和营运成本上升。依赖国际测试网络的种苗公司和育种项目也面临更高的物流成本和更复杂的海关程序，改变了2025年周期的测试计划和时间表。

在财务方面，不断变化的关税环境促使资本配置转向供应链弹性和供应商多元化。企业优先投资于供应商资质认证、库存扩张和应急计划，以维持育种计划。虽然这些措施在短期内成本高昂，但它们降低了严重中断的风险，并为能够提供一体化采购解决方案、在地化和捆绑服务模式的供应商创造了机会。展望未来，相关人员需要在成本压力与营运需求之间取得平衡，以维持高通量基因型鉴定和表型分析能力。

综合細項分析揭示了作物类型、产品结构、最终用户优先顺序和应用领域如何推动差异化采用和容量需求

关键細項分析揭示了不同作物类型、产品形态、最终用户和应用领域的差异化采用模式和策略重点。作物专案显示，谷物正在大力投资高通量基因型鉴定和大规模田间表型分析，以提高累积产量；而水果和蔬菜则优先考虑性状特异性编辑和需要精细表型分析的品质指标。油籽计画正在平衡性状复杂性和市场特定的性状组合；豆类计画则越来越注重抗逆性研究，需要对每个基因型进行深入的环境测试。

产品类型在采购和部署方面呈现出明显差异：套件和试剂等耗材是决定通量的经常性营运成本，而微阵列扫描仪、PCR系统和定序仪等设备则决定了核心竞争力和资本密集度。生技公司优先考虑平台扩充性和智慧财产权保护，研究机构重视方法检验和开放科学合作，种苗公司重视育种流程整合和法规遵循。

应用主导的细分揭示了科学研究工作的重点。例如，抗病计划需要高解析度的标记-性状关联和功能检验，抗逆性倡议依赖多环境测试和感测器主导的表型分析，而产量改进项目则整合了复杂的基因组预测模型和管理实践数据。这些细分视角揭示了投资和伙伴关係在哪些方面最有效，以及哪些方面的能力差距阻碍了进展。

美洲、中东和非洲以及亚太地区的区域动态和差异化采用模式将影响技术部署和伙伴关係策略

区域动态对分子育种领域的技术采用、监管格局和投资流向有显着的影响。在美洲，大规模的商业化育种运作以及某些基因编辑方法相对有利的法规环境，支持了整合基因型鉴定和表型分析平台的早期应用。相较之下，欧洲、中东和非洲的监管立场和研究重点各不相同，存在一些先进的学术合作领域，市场奖励也各不相同，并且越来越重视应对气候诱发压力的韧性性状。

亚太地区以其公共育种倡议、快速现代化的私营种子产业以及不断扩大的国内实验室设备生产能力而脱颖而出。区域供应链和贸易关係也会影响筹资策略。跨区域运作的组织通常采用混合部署模式，将集中式资料分析与本地样本采集和测试结合。这些地理因素决定了组织优先考虑基础设施投资、人才招募和伙伴关係关係建设，以符合监管、农艺和市场现实。

技术提供者、研究机构和商业育种者之间的策略行动和能力投资将决定新的竞争优势

领先的分子育种公司正在部署各种策略以获得竞争优势：定向收购以整合平台功能；建立合作伙伴关係以共用风险并加速检验；以及大力投资软体和资料科学，将海量数据集转化为营运决策。拥有多元化产品组合的商业公司正在将仪器销售与经常性耗材收入和服务合约结合，以平滑收益週期并将自身融入客户工作流程。

科学研究机构和合约服务供应商正在透过提供模组化服务包来应对这项挑战，这些服务包降低了小型育种专案的进入门槛，同时为大型客户保持了高通量能力。智慧财产权策略也在不断发展，科研机构选择性地保护核心演算法和性状连锁标记，同时加入协作资料共用联盟以获取更广泛的训练资料集。那些优先考虑互通性、强大的检验和强大的客户支援的公司，育种客户的留存率正在提高，并创造了从发现到商业化的长期伙伴关係机会。

为产业领导者提供可行的策略重点，以降低营运风险、加速采用并将技术进步转化为可重复的育种成果

产业领导者应优先考虑切实可行的措施，将技术潜力转化为可重复的商业性成果。首先，投资可互通的资料架构和清晰的资料管治框架，将加速多试验分析，并实现跨专案可扩展的基因组预测。其次，实现关键设备和耗材供应链的多元化，确保本地或多家供应商的供应，可以降低营运风险，并保护育种计画免受贸易和物流衝击的影响。第三，建构商业协议，透过基于里程碑的合作和成果共用机制来协调奖励，可以降低准入门槛，并将资源集中用于高影响力的目标。

此外，组织应透过聘请融合育种专业知识、资料科学和产品管理的多学科团队来扩展其内部能力，以确保分析结果能够融入育种决策。与服务供应商建立策略伙伴关係可以创造灵活的能力，而不会削弱核心竞争力。在代表性环境中进行检验测试的定向投资可以增强监管提交和市场信誉。最后，领导者必须采用投资组合思维，在颠覆性技术的探索与核心流程的精简之间取得平衡，即使在不断变化的外部环境中也能保持持续的进步。

结合专家访谈、文献综合和三段论检验的稳健混合方法研究途径可确保获得可操作和可复製的见解

该研究将对高级研发领导、采购经理和商业策略负责人的初步访谈与对同行评审文献、专利申请和上市公司资讯披露的二次分析相结合。初步资讯包括结构化访谈，以检验采用障碍、采购行为和伙伴关係模式；二次资讯则包括对基因型鉴定、表型和分析领域的技术背景和趋势的检验。

数据整合强调定性洞察与记录证据的交叉检验。调查方法保障措施包括：将供应商诉求与使用者体验进行三角检验；进行时间最后覆核以确保研究结果的时效性；以及进行敏感度评估以确定不确定性领域。分析方法将访谈的主题编码与技术能力的结构化映射相结合，使我们能够突出宏观趋势和营运优势。调查方法优先考虑透明度、可复製性和与寻求可行策略和投资指南的决策者的相关性。

全面了解技术整合、营运弹性和自适应商业模式如何决定分子育种的长期成功。

分子育种正进入成熟期，其特征是基因组学、表型组学和分析学的紧密结合，它们共同重新定义了性状的发现、检验和应用方式。技术进步、供应链调整和商业模式不断发展的累积效应，预示着一个更模组化、互联互通的育种生态系统。积极拥抱资料互通性、供应商多元化和跨学科人才的利益相关人员，将有望从加速育种週期和提高选择准确性中获益。

同时，贸易政策、不断变化的法规以及气候变迁等外部因素将继续塑造营运风险和战略机会。将严谨的技术与灵活的商业模式结合的组织将能够缓解短期干扰并保持长期价值创造。总而言之，未来几年，那些将平台级进展转化为强大的育种产品线、检验的性状组合以及能够满足农民和消费者需求的连贯上市计划的公司将获得丰厚的回报。

目录

第一章 引言

第二章分析方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 透过整合 CRISPR 碱基编辑加速小麦和水稻的多性状改良
  • 引入人工智慧驱动的表型数据分析，用于大豆育种流程中的预测选择
  • 部署泛基因组组装以识别番茄品种中的新型抗病等位基因
  • 在玉米计画中实施与无人机表型分析相结合的基因组选择模型
  • 应用基于单倍型的基因组预测提高高粱品种的耐旱性

第六章：美国关税的累积影响（2025年）

第七章：人工智慧（AI）的累积影响（2025年）

第八章 分子育种市场（依作物类型）

  • 序列
  • 水果和蔬菜
  • 油籽
  • 脉衝

第九章分子育种市场：依产品类型

  • 耗材
    • 套件
    • 试剂
  • 装置
    • 微阵列扫描仪
    • PCR体系
    • 序列器
  • 服务
    • 基因型鉴定
    • 表型分析
  • 软体
    • 生物资讯学工具
    • 数据分析平台

第 10 章 分子育种市场（依最终使用者）

  • 生技公司
  • 研究所
  • 种子公司

第 11 章分子育种市场：依应用

  • 抗病性
  • 抗压能力
  • 产量提高

第十二章分子育种市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章分子育种市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 分子育种市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 市占率分析（2024年）
  • FPNV定位矩阵（2024年）
  • 竞争分析
    • Corteva, Inc.
    • Syngenta AG
    • Groupe Limagrain
    • Bayer CropScience AG
    • KWS SAAT SE & Co. KGaA
    • Land O'Lakes, Inc.
    • BASF SE
    • Vilmorin & Cie
    • DLF-A/S
    • Sakata Seed Corporation
Product Code: MRR-43539E5D2DE9

The Molecular Breeding Market is projected to grow by USD 11.17 billion at a CAGR of 12.56% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.33 billion
Estimated Year [2025] USD 4.87 billion
Forecast Year [2032] USD 11.17 billion
CAGR (%) 12.56%

A comprehensive orientation to the integrated technological and operational forces accelerating molecular breeding and reshaping crop improvement pipelines

Molecular breeding sits at the convergence of genomics, high-throughput phenotyping, and computational analytics, forming a foundation for accelerated crop improvement. Over the last decade, improvements in sequencing throughput, reductions in genotyping costs, and refinements in phenotype acquisition have collectively transformed how breeding pipelines are designed and executed. Consequently, research and development teams can compress breeding cycles, enhance selection accuracy, and validate complex traits under diverse environmental scenarios.

This report synthesizes developments across the molecular breeding ecosystem, articulating how technology integration is modifying stakeholder behavior, capital allocation, and partnership models. It examines both incremental process improvements and paradigm shifts that are enabling more predictive breeding strategies. Importantly, the analysis situates recent technological advances within operational realities, from supply chain dependencies to regulatory constraints, offering readers a holistic view that links method-level innovation to commercial outcomes.

Contextualized for corporate leaders, investors, and research directors, the introduction frames the subsequent chapters by outlining the principal drivers of change, typical adoption pathways, and emergent value pools that merit strategic attention. By establishing this baseline, subsequent sections highlight where disruption is most likely to occur and where deliberate intervention can yield outsized returns.

How converging technological, regulatory, and commercial dynamics are reorganizing operational control and competitive advantage across molecular breeding ecosystems

The molecular breeding landscape is undergoing a series of transformative shifts driven by converging technological, regulatory, and commercial dynamics. Genotyping platforms have migrated from specialized core facilities into modular instruments that can be adopted in decentralized breeding stations, thereby shifting control of data generation closer to breeders. Parallel advances in image-based and sensor-enabled phenotyping are increasing temporal resolution and trait fidelity, enabling discovery of subtle genotype-by-environment interactions that were previously masked in field trials.

At the same time, software and analytics have evolved from descriptive reporting toward predictive modeling and decision-support systems that integrate multi-omic layers. This transition has encouraged cross-disciplinary teams to embed data scientists within breeding programs, fueling demand for interoperable data standards and cloud-native architectures. Regulatory frameworks are also adapting; jurisdictions that clarify pathways for gene-edited varieties are catalyzing investment and facilitating faster trials and commercialization.

Commercially, partnerships are more fluid and outcome-oriented, with licensing, data-sharing, and outcome-based contracts emerging as preferred mechanisms to align incentives across technology providers, seed companies, and research institutions. Together, these shifts are transforming timing, risk allocation, and the locus of competitive advantage within the sector.

Assessment of how the 2025 United States tariff measures altered procurement, supply chain resilience, and operational timelines for molecular breeding stakeholders

United States tariff actions implemented in 2025 have produced a cascade of effects across procurement, supply chain resilience, and commercialization timelines for molecular breeding stakeholders. Tariffs on laboratory equipment components and certain specialty consumables have increased landed costs for instruments and reagents, prompting procurement teams to reassess sourcing strategies and inventory policies. As a result, some organizations have shifted toward multi-sourcing and nearshoring to mitigate exposure, while others have extended equipment life cycles and accelerated validation of alternative suppliers.

These trade policy changes have also amplified the importance of domestic manufacturing capacity for critical instrumentation and high-value consumables. Firms with in-country production or long-term supplier partnerships have gained procurement leverage, whereas smaller research outfits reliant on single-source imports experienced project delays and higher operating expenses. In turn, seed companies and breeding programs that depend on international trial networks encountered higher logistical costs and more complex customs procedures, which altered trial planning and timing in the 2025 cycle.

Financially, the tariff environment has shifted capital allocation toward supply chain flexibility and vendor diversification. Companies prioritized investments in vendor qualification, extended inventory, and contingency planning to preserve breeding timelines. While these measures incurred short-term costs, they reduced the risk of severe disruptions and created opportunities for suppliers that could offer integrated procurement solutions, localization, or bundled service models. Going forward, stakeholders will need to balance cost pressures with the operational imperative to maintain high-throughput genotyping and phenotyping capabilities.

Integrated segmentation analysis revealing how crop types, product architectures, end-user priorities, and application areas drive differentiated adoption and capability needs

Key segmentation analysis reveals differentiated adoption patterns and strategic priorities across crop types, product forms, end users, and application areas. Crop-focused programs show that cereals often attract high-throughput genotyping and large-scale field phenotyping investments aimed at cumulative yield gains, while fruits and vegetables prioritize trait-specific edits and quality metrics that require fine-grained phenotyping. Oilseeds programs balance trait complexity with market-specific trait stacks, and pulses are increasingly the focus of stress-tolerance efforts that require concentrated genotype-by-environment trials.

Product-type segmentation demonstrates clear distinctions in procurement and deployment. Consumables, including kits and reagents, are the recurring operational expense that determines throughput; instruments such as microarray scanners, PCR systems, and sequencers define core capability and capital intensity; services spanning genotyping and phenotyping create flexible capacity and access to expertise; and software, from bioinformatics tools to data analysis platforms, drives the translation of raw data into selection decisions. End-user segmentation further differentiates needs: biotechnology firms prioritize platform scalability and IP protection, research institutions emphasize methodological validation and open-science collaboration, and seed companies focus on integration into breeding pipelines and regulatory compliance.

Application-led segmentation highlights where scientific efforts concentrate: disease resistance projects demand high-resolution marker-trait associations and functional validation, stress tolerance initiatives rely on multi-environment trials and sensor-driven phenotyping, and yield enhancement programs integrate complex genomic prediction models with management practice data. These segmentation lenses together expose where investments and partnerships are most effective and where capability gaps constrain progress.

Regional dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape technology deployment and partnership strategies

Regional dynamics exert a strong influence on technology adoption, regulatory posture, and investment flows across the molecular breeding landscape. In the Americas, large commercial breeding operations and a relatively favorable regulatory environment for certain gene-editing approaches have driven early adoption of integrated genotyping and phenotyping platforms, while strong private-sector R&D spending has supported rapid scale-up of field trials and commercialization pathways. In contrast, Europe, the Middle East & Africa present a heterogeneous mix of regulatory stances and research priorities, with pockets of advanced academic collaboration, variable market incentives, and an increasing focus on resilience traits to address climate-driven stressors.

Asia-Pacific stands out for its combination of significant public-sector breeding initiatives, rapidly modernizing private seed industries, and growing domestic manufacturing capacity for lab instrumentation. Regional supply chains and trade relationships also influence procurement strategies; organizations operating across multiple regions often adopt hybrid deployment models that combine centralized data analytics with localized sample collection and trial execution. These geographic considerations shape where organizations prioritize infrastructure investment, talent recruitment, and partnership building to align with regulatory, agronomic, and market realities.

Strategic behaviors and capability investments among technology providers, research institutions, and commercial breeders that define emerging competitive advantage

Leading organizations in molecular breeding are deploying a mixture of strategic moves to secure competitive positions: targeted acquisitions to integrate platform capabilities, alliance formation to share risk and accelerate validation, and focused investments in software and data science to translate large datasets into operational decisions. Commercial players with diversified portfolios are coupling instrument sales with recurring consumable revenues and service contracts, thereby smoothing revenue cycles and embedding themselves into customer workflows.

Research institutions and contract service providers are responding by offering modular service packages that reduce barriers to entry for smaller breeding programs while preserving high-throughput capacity for larger clients. Intellectual property strategies are evolving as well, with organizations selectively protecting core algorithms and trait-linked markers while participating in collaborative data-sharing consortia to access broader training datasets. Companies that prioritize interoperability, robust validation, and strong customer support have improved retention rates among breeding customers, creating opportunities for long-term partnerships that extend from discovery through commercialization.

Actionable strategic priorities for industry leaders to de-risk operations, accelerate adoption, and convert technological advances into repeatable breeding outcomes

Industry leaders should prioritize actionable steps that convert technological potential into repeatable commercial outcomes. First, investing in interoperable data architectures and clear data governance frameworks will accelerate multi-trial analytics and enable scalable genomic prediction across programs. Second, diversifying supply chains for critical instruments and consumables while qualifying local or multiple suppliers will reduce operational risk and protect breeding schedules from trade and logistic shocks. Third, structuring commercial agreements to align incentives-through milestone-based collaborations or outcome-sharing mechanisms-will lower barriers to access and concentrate resources on high-impact objectives.

Furthermore, organizations should expand internal capabilities by hiring cross-disciplinary teams that blend breeding expertise, data science, and product management to ensure that analytical outputs are translated into breeding decisions. Strategic partnerships with service providers can create flexible capacity without diluting core competencies, and targeted investment in validation trials across representative environments will strengthen regulatory dossiers and market credibility. Finally, leaders must adopt a portfolio mindset, balancing exploration of disruptive technologies with consolidation of core process efficiencies to maintain consistent progress under changing external conditions.

Robust mixed-method research approach combining expert interviews, literature synthesis, and triangulated validation to ensure actionable and reproducible insights

This research synthesizes primary interviews with senior R&D leaders, procurement managers, and commercial strategy executives, combined with secondary analysis of peer-reviewed literature, patent filings, and public company disclosures. Primary engagement included structured interviews to validate adoption barriers, procurement behaviors, and partnership models, while secondary sources provided technical context and trend validation across genotyping, phenotyping, and analytics domains.

Data synthesis emphasized cross-validation between qualitative insights and documented evidence. Methodological safeguards included triangulation of supplier claims with user experiences, temporal cross-checks to ensure currency of findings, and sensitivity reviews to identify areas of elevated uncertainty. Analytical approaches integrated thematic coding of interviews with structured mapping of technology capabilities, enabling the report to highlight both macro trends and operational levers. The methodology prioritizes transparency, reproducibility, and relevance to decision-makers seeking pragmatic guidance for strategy and investment.

Synthesis of how technological integration, operational resilience, and adaptive commercial models will determine long-term success in molecular breeding

Molecular breeding is entering a maturation phase characterized by tighter integration of genomics, phenomics, and analytics, which together are redefining how traits are discovered, validated, and deployed. The cumulative effect of technological advances, supply chain adjustments, and evolving commercial models points toward more modular yet interconnected breeding ecosystems. Stakeholders that proactively address data interoperability, supplier diversification, and cross-disciplinary talent will be well-positioned to capture the benefits of accelerated breeding cycles and improved selection accuracy.

At the same time, external factors such as trade policy, regulatory evolution, and climate variability will continue to shape operational risk and strategic opportunity. Organizations that combine technical rigor with flexible commercial models can both mitigate short-term disruptions and sustain long-term value creation. In summary, the coming years will reward those who translate platform-level advances into robust breeding pipelines, validated trait packages, and coherent go-to-market programs that respond to farmer and consumer needs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of CRISPR base editing to accelerate multi-trait improvement in wheat and rice
  • 5.2. Adoption of AI-driven phenomic data analytics for predictive selection in soybean breeding pipelines
  • 5.3. Deployment of pangenome assemblies to identify novel disease resistance alleles in tomato varieties
  • 5.4. Implementation of genomic selection models coupled with UAV-based phenotyping in maize programs
  • 5.5. Application of haplotype-based genomic prediction to improve drought tolerance in sorghum cultivars

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Molecular Breeding Market, by Crop Type

  • 8.1. Cereals
  • 8.2. Fruits & Vegetables
  • 8.3. Oilseeds
  • 8.4. Pulses

9. Molecular Breeding Market, by Product Type

  • 9.1. Consumables
    • 9.1.1. Kits
    • 9.1.2. Reagents
  • 9.2. Instruments
    • 9.2.1. Microarray Scanners
    • 9.2.2. PCR Systems
    • 9.2.3. Sequencers
  • 9.3. Services
    • 9.3.1. Genotyping
    • 9.3.2. Phenotyping
  • 9.4. Software
    • 9.4.1. Bioinformatics Tools
    • 9.4.2. Data Analysis Platforms

10. Molecular Breeding Market, by End User

  • 10.1. Biotechnology Firms
  • 10.2. Research Institutions
  • 10.3. Seed Companies

11. Molecular Breeding Market, by Application

  • 11.1. Disease Resistance
  • 11.2. Stress Tolerance
  • 11.3. Yield Enhancement

12. Molecular Breeding Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Molecular Breeding Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Molecular Breeding Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Corteva, Inc.
    • 15.3.2. Syngenta AG
    • 15.3.3. Groupe Limagrain
    • 15.3.4. Bayer CropScience AG
    • 15.3.5. KWS SAAT SE & Co. KGaA
    • 15.3.6. Land O'Lakes, Inc.
    • 15.3.7. BASF SE
    • 15.3.8. Vilmorin & Cie
    • 15.3.9. DLF-A/S
    • 15.3.10. Sakata Seed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MOLECULAR BREEDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. MOLECULAR BREEDING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. MOLECULAR BREEDING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MOLECULAR BREEDING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MOLECULAR BREEDING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MOLECULAR BREEDING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. GCC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. GCC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. GCC MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. GCC MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. GCC MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. GCC MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. GCC MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 332. GCC MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 333. GCC MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 334. GCC MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 335. GCC MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 336. GCC MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 337. GCC MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 338. GCC MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 339. GCC MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. GCC MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. GCC MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-202